Insider · CIK 0002018150
Charles David Pauza
Files at TRAW (Onconova Therapeutics, Inc.). First filing -, latest -.
In brief
Charles David Pauza files SEC Form 4 as officer at TRAW (Onconova Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles David Pauza has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +97,000 | $0.00 | $0 | 97,000 | Jul 16, 2026 |
| Mar 8, 2026 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +118,367 | $0.00 | $0 | 118,367 | Mar 10, 2026 |
| Dec 12, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Common Stock | +18,471 | $0.00 | $0 | 115,971 | Dec 16, 2025 |
| Dec 12, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to purchase)derivative | +73,886 | $0.00 | $0 | 73,886 | Dec 16, 2025 |
| Oct 12, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to purchase)derivative | +32,406 | $0.00 | $0 | 32,406 | Oct 15, 2025 |
Questions about Charles David Pauza
Answered from the filings on this page, as of the latest one.
Is Charles David Pauza buying or selling?
Charles David Pauza has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles David Pauza's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles David Pauza has 0.
Where does Charles David Pauza file Form 4?
Charles David Pauza has filed Form 4 at TRAW (Onconova Therapeutics, Inc.) as Chief Science Officer Virology. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.